INFO
AGENDA
REGISTRATION
CME
PLANNING COMMITTEE
SPONSORSHIPS
ABSTRACTS

Ovarian Cancer Research Seminar Series

The Rivkin Center and the American Association for Cancer Research are proud to present the Virtual Ovarian Cancer Research Seminar Series in September 2022 in honor of Ovarian Cancer Awareness Month.

 

SEMINAR SERIES INFO

The 14th Biennial Ovarian Cancer Research Symposium will take place in the form of a Virtual Seminar Series that will provide an educational opportunity and keep our community connected. The goal of the Seminar Series is to bring together clinicians and researchers from across many disciplines and institutions worldwide to share ideas and advance the field of ovarian cancer research. The Seminars seek to enhance the understanding and knowledge of ovarian cancer, discuss the most recent innovations in the field of ovarian cancer research, and address pressing concerns of the leaders in the clinical and research community.

The Seminar topics were developed by our Planning Committee and each Seminar will feature invited lectures by experts in the field, as well as Lightning Round talks from selected abstracts. Abstracts not selected for the Lightning Round talks may be invited to submit a virtual poster. AMA PRA Category 1 Credit(s)TM will be offered for the live, virtual activity. Registration will cover all four Seminars; you cannot register for individual Seminars. For registrants who are unable to join us live, recordings of the Seminars will be made available OnDemand for 90 days on the AACR website.

Continuing Medical Education Activity – AMA PRA Category 1 CreditsTM available. Visit the CME tab for more information.

SEMINAR TOPICS
  • Precision Medicine
  • Immuno-oncology
  • Prevention and Early Detection
  • Healthcare Disparities and Patient Advocacy
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM will be available.
CONTACT

For questions, please contact Jackie Lang at jackie.lang@rivkin.org or (206)490-0847 x104.

To join the live, virtual seminars, you must register for the Seminar Series. Please visit the Registration tab. 

Each seminar will consist of two full-length talks from invited experts, a round of 5-minute lightning round talks from selected abstracts, and a fireside chat, where the two main presenters and the moderator will dive into a deeper discussion of the challenges and future directions of that specific field.

The four seminars will take place on September 21, 22, 28, and 29, 2022 from 12-2 pm PDT.

Seminar Agenda

The agenda for each two-hour seminar will be roughly as follows. Please note that all times are in Pacific Time.

12:00 PM – 12:05 PM

12:05 PM – 12:35 PM

12:35 PM – 1:05 PM

1:05 PM – 1:40 PM

1:40 PM – 2:00 PM

Welcome & Intro

Speaker 1 (talk & Q&A)

Speaker 2 (talk & Q&A)

Lightning Round talks (5 5-minute talks & group Q&A)

Fireside Chat

Wednesday, September 21, 2022
Precision Medicine

Moderator


Speaker 1

Neil Johnson, PhD
Fox Chase Cancer Center

Clare Scott, MB, PhD
University of Melbourne

Speaker 2

Additional Expert

Rugang Zhang, PhD
The Wistar Institute

James Lillard, PhD, MBA
Morehouse

Thursday, September 22, 2022
Prevention and Early Detection

Moderator


Speaker 1

Goli Samimi, PhD
National Cancer Institute

Kathryn Alsop, PhD
Peter MacCullum Cancer Centre in Melbourne

Speaker 2

Kathryn Pennington, MD
University of Washington

Wednesday, September 28, 2022
Immuno-oncology

Moderator


Speaker 1

Christina Annunziata, MD
National Cancer Institute

Jose Conejo-Garcia, MD, PhD
Moffitt Cancer Center

Speaker 2

Tonya Webb, PhD
University of Maryland

Thursday, September 29, 2022
Healthcare Disparities & Patient Advocacy

Moderator


Speaker 1

Sarah Temkin, MD
National Cancer Institute

Tomi Akinyemiju, PhD
Duke University School of Medicine

Speaker 2

Sophia George, PhD
University of Miami

Registration

Individuals wishing to participate in the seminar series must register online through the link above. Registration will not be processed without full payment. All fees must be in U.S. currency, drawn on a U.S. bank. Visa, MasterCard, and American Express are also accepted for payment. Online registrations will be confirmed by email immediately. Receipts can also be obtained online.

Please note: Registration includes access to all four (4) dates of the Virtual Seminar Series. Single session registration is not available.

Registration Rates

1 Nonmember pre/postdoctoral students must have their registrar, dean, or department head certify that they are enrolled at the university and working toward a degree or fellowship in a field related to cancer research.

2 If you have not previously participated in any AACR activity as a Patient Advocate or Survivor, please complete the advocate verification form to request the complementary registration for this seminar series. The AACR Survivor and Patient Advocacy Department will contact you regarding approval. Email advocacy@aacr.org for questions.

ACCESSING THE VIRTUAL SEMINAR SERIES

Registrants must log in to myAACR and go to “Events” to access the seminar series. The “Attend” button on your digital ticket will become enabled approximately 30 minutes prior to the first session.

The virtual seminar series platform will be available starting on September 21, 2022, at 11:30 am PT/2:30 pm ET and will provide access to live sessions and platform to submit questions, view the final program, abstracts being presented, short video presentations of posters, supporters, and related series information. Sessions (synchronized slides and audio) will be available by October 13 for on-demand viewing and will remain available until December 29, 2022.

REFUND POLICY

Requests for refunds must be made in writing and received by the AACR Meetings Department by September 1, 2022.  Refund requests may be sent to meetings@aacr.org. There will be a $75 administrative fee for processing cancellations received by September 1, 2022. After this date, no refunds can be given.

Continuing Medical Education (CME)

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The American Association for Cancer Research (AACR) and the Rivkin Center for Ovarian Cancer. The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) activities for physicians.

CREDIT DESIGNATION STATEMENT

AACR has designated this internet live activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.

CLAIMING (CME) CREDIT

Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)TM for this live continuing medical education activity must complete the online CME Request for Credit Survey by Wednesday, November 18, 2022. Certificates will only be issued to those who complete the survey. The Request for Credit Survey will be available via a link on the 14th Biennial Ovarian Cancer Research Symposium website or via email. Your CME certificate will be sent to you via email after the completion of the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.  

STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES

Approximately 19,880 women in the United States will be diagnosed with ovarian cancer this year. The overall 5-year survival rate is only 50% for ovarian cancer –lower in African-American women, and the rate is markedly lower for advanced stage cancers. Sadly, the survival rates have only improved slightly over 40 years, and access to healthcare and other socioeconomic factors present additional obstacles to improved outcomes. While ovarian cancer is the most deadly gynecologic cancer, it is underrepresented in both research funding and research participants. Additionally complicating the difficulty in diagnosing the disease beyond its physical complexities is that ovarian cancer is a rare disease and many providers will have limited access to information on the signs, symptoms, and latest techniques to diagnose the disease.

In this course we are addressing major needs in ovarian cancer care and research by educating health care providers and researchers in the latest research on improving treatment, early detection, and prevention, as well as recognizing healthcare disparities and promoting a better understanding of the many diseases under the umbrella of ovarian cancer.

  1. Attendees will need access to and updates on the most recent research in a wide array of topics including novel treatment methods, best early detection techniques, basic biology and categorization of the disease, and recent data on risk, prevention, and progression of ovarian cancer.
  2. Attendees will need information on recent trends in specialized fields such as cancer control strategies and immunotherapy to understand the continuum between prevention and cure.
  3. Attendees will need opportunities to network with other experts in the field to initiate collaborations in research and in clinical care.

 

The Planning Committee has designed this event to benefit the following audiences: basic scientists, epidemiologists, clinical scientists, and clinicians as well as geneticists, public health researchers, nurses, and advocates for ovarian cancer research. This conference encourages the collaboration between professionals with a wide variety of expertise including: gynecologic oncology, medical oncology, pathology, genetics, molecular biology, cell biology, public health, behavioral epidemiology, translational research, patient care, and patient advocacy.

After participating in this CME activity, physicians should be able to:

  • Define cancer control strategies to detect ovarian cancer at the earliest stages and to prevent the disease
  • Identify model systems that best recapitulate ovarian cancer
  • Distinguish the clinical and biological considerations of rare subtypes of ovarian cancer
  • Articulate how DNA Repair and other molecular mechanisms impact ovarian cancer development and treatment
  • Explain the elements of tumor microenvironment and immunology as they contribute to ovarian cancer growth and as possible targets for treatment
  • Identify novel therapies against ovarian cancer and assess the response and resistance of new therapies
  • Detect signs of racial disparities in quality of cancer care

DISCLOSURE STATEMENT

It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, AACR will provide information that Scientific Program Committee members and speakers have disclosed all financial relationships they have with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products or services used by or on patients. All of the relevant financial relationships for these individuals have been mitigated.

ACKNOWLEDGMENT OF FINANCIAL OR OTHER SUPPORT

This activity is supported by Professional Educational Grants and will be disclosed at the activity.

QUESTIONS ABOUT CME?

Please contact the Office of CME at (215) 440-9300 or cme@aacr.org.

Ovarian Cancer Seminar Series Planning Committee

The purpose of the Planning Committee is to develop the scope and goals of the 14th Biennial Ovarian Cancer Research Symposium, which will take place in the form of a virtual seminar series. The members’ collective expertise informed the selection of invited speakers, topics of the seminars, and all elements of the programming. The seminar series seeks to enhance the understanding and knowledge of ovarian cancer, especially among junior and young investigators, discuss the most recent innovations in the field of ovarian cancer research, and address the pressing concerns among the leaders of the clinical and research community.

Planning Committee Members:

Christina Annunziata, MD, PhD
Co-Chair

alth

Neil Johnson, PhD
Co-Chair

James Lillard,
PhD, MBA
Co-Chair

Goli Samimi, PhD, MPH
Co-Chair

Jackie Lang, PhD
Rivkin Center

Dean Post
American Association for Cancer Research

Sponsorships

For more information about sponsoring this year’s event, please review our sponsorship packet or contact Wendy Rosen, Director of Development, at wendy.rosen@rivkin.org or (206) 584-2271.

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors

Call for Abstracts

We are accepting research and clinical abstracts in all fields of ovarian cancer research. Select abstracts will be invited to present 5-minute lightning talks during the live virtual seminars. Other abstracts may be invited to submit 5-minute prerecorded virtual poster presentations which will be available OnDemand to all seminar registrants.

Abstract presenters (lightning talks or virtual posters) must register for the seminars. Please carefully review the Abstract Submission Guidelines before submitting your abstract.

ABSTRACTS

Individuals interested in submitting an abstract for presentation during the series must do so through the myAACR online abstract submission service below. Abstract submissions will only be accepted electronically; paper abstracts will not be accepted. The abstract submission deadline is Monday, July 18, 2022, 12 pm PT/3 pm ET.

ABSTRACT SUBMISSION GUIDELINES

Download and print the abstract submission guidelines.

ABSTRACT CATEGORIES

  • Healthcare Disparities and Patient Advocacy
  • Immuno-Oncology
  • Precision Medicine
  • Prevention and Early Detection
  • Other

NOTIFICATION OF ABSTRACT STATUS

All individuals listed as ABSTRACT PRESENTERS will be notified of acceptance or rejection by email approximately four weeks after the abstract submission deadline. Notices and instructions will be sent to the email address provided at the time of abstract submission. If an abstract is not selected for presentation, the presenter may request a full refund of the registration fee by contacting the AACR Meetings Department at meetings@aacr.org.

PRESENTATION & PUBLICATION

Abstracts selected for presentation during the seminar series (oral presentations or video posters) will be posted on the virtual meeting platform at 11:30 am PT/2:30 pm ET on September 21, 2022. Every effort will be made to reproduce the content of the abstracts as submitted, except in certain circumstances where changes may be made to comply with AACR style. Abstract titles and authors (no data) may be posted on the seminar series website prior to the release of the full abstracts on September 21.

Instructions will be sent to the ABSTRACT PRESENTERS with the date, time, and format for their presentations.

REGISTRATION

If an abstract is not accepted for presentation, the ABSTRACT PRESENTER may request a full refund of the registration fee. For additional information, please visit the Registration webpage.

REQUEST FOR WITHDRAWAL

Once an abstract has been submitted, it may be withdrawn only by written request from the ABSTRACT PRESENTER. The request may be emailed to programs@aacr.org and must be received by Friday, August 26.

The Virtual Ovarian Cancer Research Seminar Series is a CME Activity jointly provided by the American Association for Cancer Research and the Rivkin Center.

Color Rivkin Center Logo